The WHO Country Representative, Fiona Braka, while fielding questions, stated that research was going on globally for a COVID-19 vaccine.
According to Braka, no fewer than 89 products are undergoing development.
He stated, “Research is going on globally to study the genetics of the virus. This helps us to develop a vaccine. Thanks to the rapid sharing of genetic data from countries, we are able to advance the production of vaccines.
“We do acknowledge the contributions of countries in sharing their genetic sequencing data, including Nigeria. So, the first vaccine trial started as early as 60 days just after the genetic sequencing information of the virus was shared by China.
“We have about 89 products that are currently under vaccine development. The numbers keep getting updated because there is an accelerated process going on globally to try and find a vaccine.”
The WHO Representative in Nigeria, Fiona Braka had said that research was ongoing globally for a coronavirus vaccine.
Braka stated this on Monday while answering questions during the Presidential Taskforce on COVID-19.
Braka added that no fewer than 89 products are undergoing development.
According to him, “Research is going on globally to study the genetics of the virus. This helps us to develop a vaccine. Thanks to the rapid sharing of genetic data from countries, we are able to advance the production of vaccines.
“We do acknowledge the contributions of countries in sharing their genetic sequencing data, including Nigeria. So, the first vaccine trial started as early as 60 days just after the genetic sequencing information of the virus was shared by China.
“We have about 89 products that are currently under vaccine development. The numbers keep getting updated because there is an accelerated process going on globally to try and find a vaccine.”
